Home/Filings/4/0001437749-26-000429
4//SEC Filing

CODE KENNETH REAY 4

Accession 0001437749-26-000429

CIK 0000880242other

Filed

Jan 4, 7:00 PM ET

Accepted

Jan 5, 7:06 PM ET

Size

14.9 KB

Accession

0001437749-26-000429

Insider Transaction Report

Form 4
Period: 2025-12-31
CODE KENNETH REAY
DirectorChief Technology Officer10% Owner
Transactions
  • Award

    Common Stock

    2025-12-31$0.18/sh+54,803$10,10025,806,308 total
Footnotes (3)
  • [F1]The shares issued are subject to a Lock-Up Agreement dated as of the issuance date whereby shares are locked-up and restricted from sale until the Issuer reports gross revenue of at least $40 million on a consolidated basis for any reported period (e.g, quarter or annual), or the Issuer's market capitalization exceeds $300 million, or there is a "change in control" in the Issuer.
  • [F2]Shares received from Issuer in exchange for a reduction in amounts owed by Issuer to Reporting Person for salary and unreimbursed business expenses (equal to the product of the number of shares and acquisition price per share).
  • [F3]Aggregate total shares includes 22,139,012 shares owned indirectly by Reporting Person through a wholly owned corporation.

Issuer

BIOLARGO, INC.

CIK 0000880242

Entity typeother

Related Parties

1
  • filerCIK 0001370684

Filing Metadata

Form type
4
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 7:06 PM ET
Size
14.9 KB